[Treatment of systemic lupus erythematosus with intravenous human immunoglobulins. Preliminary study].
Recently the availability of human immunoglobulin for intravenous use (IVIg) has been helpful in the treatment of some conditions characterized by autoimmune disorders and anecdotal reports have been suggested a favourable role in the therapy of SLE. We report our experience on 4 SLE patients in whom IVIg was administered. Our data suggest that IVIg may be considered an alternative regimen to treat selected patients affected by SLE.
Migliaresi
S
S
I Facoltà di Medicina, Università degli Studi di Napoli Federico II.
Gallo
M
M
Tirri
G
G
D000328:Adult; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D008297:Male
D016756:Immunoglobulins, Intravenous
Trattamento del lupus eritematoso sistemico con immunoglobuline umane in vena. Studio preliminare.